Ignite Creation Date:
2024-07-17 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465953
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-14
Brief Title:
Ivosidenib IVO Monotherapy and Azacitidine AZA Monotherapy in Patients With Hypomethylating Agent HMA Naive Myelodysplastic Syndromes MDS With an IDH1 Mutation
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Servier
Organization Data
Organization:
Servier
Class:
INDUSTRY
Study ID:
S095031-178
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut de Recherches Internationales Servier
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Servier Bio-Innovation LLC | INDUSTRY |